A major European study has been published showing for the first time that colon cancer risk can be reduced by taking a dietary supplement containing the prebiotic ingredient, Beneo Synergy1 from Belgian firm Orafti.
Taking a daily synbiotic containing Beneo Synergy1 had a favourable impact on several biomarkers of colon cancer, said Orafti. "This has implications for millions of people who risk developing colon cancer."